Guidelines Navigating the GuidelinesChapter 1 - An Introduction to the Guidelines for the Treatment of Alcohol ProblemsChapter 2 - Prevalence of Alcohol Consumption and Related Harms in AustraliaChapter 3 - Stigma and DiscriminationChapter 4 - Screening and AssessmentChapter 5 - Models of CareChapter 6 - Brief Interventions for Alcohol Use and Related ProblemsChapter 7 - Brief e-Health Interventions For Alcohol Use and Related ProblemsChapter 8 - Alcohol WithdrawalChapter 9 - Psychosocial InterventionsChapter 10 - PharmacotherapiesPharmacotherapiesOverview of PharmacotherapiesFront-Line Pharmacotherapy: TGA-Approved MedicationsFirst-Line Medication: TGA-Approved but Not Available in AustraliaNalmefeneSecond-Line Pharmacotherapies: Off-Label MedicationConcurrent Psychosocial InterventionsChapter 11 - Peer Support ProgramsChapter 12 - Adolescents and YouthChapter 13 - Gender-Specific IssuesChapter 14 - Pregnant and Breastfeeding WomenChapter 15 - Aboriginal and Torres Strait Islander PeoplesChapter 16 - Culturally and Linguistically Diverse GroupsChapter 17 - Sexuality and Gender Diverse PopulationsChapter 18 - Older PeopleChapter 19 - Cognitive ImpairmentChapter 20 - Comorbidities: Alcohol with Polydrug UseChapter 21 - Comorbidities: Co-Occurring Mental and Alcohol Use DisordersChapter 22 - Comorbidities: Medical Complications of Alcohol Use DisordersChapter 23 - Relapse Prevention, Aftercare, and Long-Term Follow-Up Download Guideline First-Line Medication: TGA-Approved but Not Available in Australia Nalmefene